Proficio Capital Partners LLC Invests $608,000 in Bruker Co. (NASDAQ:BRKR)

Proficio Capital Partners LLC bought a new position in Bruker Co. (NASDAQ:BRKR) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 10,376 shares of the medical research company’s stock, valued at approximately $608,000.

Several other institutional investors also recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp raised its position in Bruker by 7.6% in the fourth quarter. Bank of New York Mellon Corp now owns 988,863 shares of the medical research company’s stock worth $57,967,000 after acquiring an additional 69,806 shares during the period. South Dakota Investment Council purchased a new stake in shares of Bruker during the 4th quarter worth approximately $703,000. Ieq Capital LLC increased its stake in shares of Bruker by 961.0% during the 4th quarter. Ieq Capital LLC now owns 58,950 shares of the medical research company’s stock worth $3,456,000 after purchasing an additional 53,394 shares during the last quarter. Alberta Investment Management Corp purchased a new stake in shares of Bruker during the 4th quarter worth approximately $598,000. Finally, Global Retirement Partners LLC increased its stake in shares of Bruker by 16.5% during the 4th quarter. Global Retirement Partners LLC now owns 5,135 shares of the medical research company’s stock worth $301,000 after purchasing an additional 726 shares during the last quarter. Institutional investors own 79.52% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on BRKR shares. Barclays decreased their price target on shares of Bruker from $69.00 to $65.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Bank of America raised their price target on shares of Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. UBS Group started coverage on shares of Bruker in a research note on Tuesday, December 10th. They set a “neutral” rating and a $66.00 price target for the company. Stifel Nicolaus decreased their price target on shares of Bruker from $70.00 to $57.00 and set a “hold” rating for the company in a research note on Friday, February 14th. Finally, The Goldman Sachs Group upgraded shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 price target for the company in a research note on Thursday, December 5th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $70.50.

Bruker Stock Up 0.4 %

BRKR opened at $48.41 on Monday. The company has a fifty day moving average price of $54.97 and a 200-day moving average price of $59.00. The firm has a market capitalization of $7.34 billion, a P/E ratio of 63.70, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 0.77. Bruker Co. has a one year low of $45.29 and a one year high of $94.86.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Equities research analysts expect that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Bruker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Stockholders of record on Monday, March 17th will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, March 17th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.41%. Bruker’s dividend payout ratio (DPR) is currently 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.